GB9718110D0 - Peptides - Google Patents

Peptides

Info

Publication number
GB9718110D0
GB9718110D0 GBGB9718110.1A GB9718110A GB9718110D0 GB 9718110 D0 GB9718110 D0 GB 9718110D0 GB 9718110 A GB9718110 A GB 9718110A GB 9718110 D0 GB9718110 D0 GB 9718110D0
Authority
GB
United Kingdom
Prior art keywords
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB9718110.1A
Other versions
GB2328689A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Norsk Hydro ASA
Original Assignee
Norsk Hydro ASA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norsk Hydro ASA filed Critical Norsk Hydro ASA
Priority to GB9718110A priority Critical patent/GB2328689A/en
Publication of GB9718110D0 publication Critical patent/GB9718110D0/en
Priority to JP2000507707A priority patent/JP2001514190A/en
Priority to PCT/NO1998/000252 priority patent/WO1999010382A1/en
Priority to EP98946725A priority patent/EP1009771A1/en
Priority to CA002301840A priority patent/CA2301840A1/en
Priority to AU93677/98A priority patent/AU9367798A/en
Publication of GB2328689A publication Critical patent/GB2328689A/en
Priority to NO20000976A priority patent/NO20000976L/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
GB9718110A 1997-08-27 1997-08-27 Peptides based on the p21 ras proto-oncogene protein for the treatment of cancer Withdrawn GB2328689A (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GB9718110A GB2328689A (en) 1997-08-27 1997-08-27 Peptides based on the p21 ras proto-oncogene protein for the treatment of cancer
JP2000507707A JP2001514190A (en) 1997-08-27 1998-08-26 Peptides that elicit cytotoxic T cell immunity
PCT/NO1998/000252 WO1999010382A1 (en) 1997-08-27 1998-08-26 Peptides which elicit cytotoxic t cellular immunity
EP98946725A EP1009771A1 (en) 1997-08-27 1998-08-26 Peptides which elicit cytotoxic t cellular immunity
CA002301840A CA2301840A1 (en) 1997-08-27 1998-08-26 Peptides which elicit cytotoxic t cellular immunity
AU93677/98A AU9367798A (en) 1997-08-27 1998-08-26 Peptides which elicit cytotoxic t cellular immunity
NO20000976A NO20000976L (en) 1997-08-27 2000-02-25 peptides

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9718110A GB2328689A (en) 1997-08-27 1997-08-27 Peptides based on the p21 ras proto-oncogene protein for the treatment of cancer

Publications (2)

Publication Number Publication Date
GB9718110D0 true GB9718110D0 (en) 1997-10-29
GB2328689A GB2328689A (en) 1999-03-03

Family

ID=10818083

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9718110A Withdrawn GB2328689A (en) 1997-08-27 1997-08-27 Peptides based on the p21 ras proto-oncogene protein for the treatment of cancer

Country Status (6)

Country Link
EP (1) EP1009771A1 (en)
JP (1) JP2001514190A (en)
AU (1) AU9367798A (en)
CA (1) CA2301840A1 (en)
GB (1) GB2328689A (en)
WO (1) WO1999010382A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO315238B1 (en) 1998-05-08 2003-08-04 Gemvax As Peptides derived from reading frame shift mutations in the TBF <beta> II or BAX gene, and pharmaceutical compositions containing them, nucleic acid sequences encoding such peptides, plasmids, and virus vector-encompassing such nucleic acid
NO309798B1 (en) * 1999-04-30 2001-04-02 Targovax As Peptide composition, as well as pharmaceutical composition and cancer vaccine including the peptide composition
CN1321661A (en) * 2000-04-29 2001-11-14 上海博德基因开发有限公司 Novel polypeptide-human K-ras proto-oncogene protein 36 and polynucleotide for coding this polypeptide
FR2836684B1 (en) * 2002-03-04 2004-12-17 Inst Nat Sante Rech Med RAS MUTED PEPTIDES AND THEIR USE IN IMMUNOTHERAPY
SG11201604644QA (en) * 2013-12-09 2016-07-28 Targovax Asa A peptide mixture
JP2017514847A (en) 2014-05-06 2017-06-08 タルゴバックス エーエスエー Peptide vaccine comprising a mutant RAS peptide and a chemotherapeutic agent
SG11201704155UA (en) * 2014-11-26 2017-06-29 Us Health Anti-mutated kras t cell receptors
EP3310808A1 (en) * 2015-06-16 2018-04-25 Targovax Asa Mutated fragments of the ras protein
JP6993402B2 (en) 2016-08-02 2022-02-03 アメリカ合衆国 Anti-KRAS-G12D T cell receptor
JP2020514321A (en) 2017-02-01 2020-05-21 モデルナティーエックス， インコーポレイテッド Immunomodulatory therapeutic mRNA composition encoding an activated oncogene variant peptide
WO2023060148A1 (en) * 2021-10-05 2023-04-13 The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services Augmentation of innate and adaptive immunity by inhibition of interaction of lilrbs with mhc-1

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9103974D0 (en) * 1991-02-26 1991-04-10 Norsk Hydro As Therapeutically useful peptides or peptide fragments
ES2180045T3 (en) * 1996-04-19 2003-02-01 Us Gov Sec Health RUT MUTED PEPTIDES FOR THE GENERATION OF CD8 + CYTOTOXY T LYMPHOCYTES.

Also Published As

Publication number Publication date
WO1999010382A1 (en) 1999-03-04
JP2001514190A (en) 2001-09-11
AU9367798A (en) 1999-03-16
EP1009771A1 (en) 2000-06-21
GB2328689A (en) 1999-03-03
CA2301840A1 (en) 1999-03-04

Similar Documents

Publication Publication Date Title
PL344341A1 (en) Peptides
PL318017A1 (en) Peptides
GB9703681D0 (en) Protein complemention
GB9719879D0 (en) Protein
GB9718110D0 (en) Peptides
EP1018551A4 (en) Megsin protein
AU1999999A (en) Contryphan peptides
GB9700154D0 (en) Peptides
GB9812675D0 (en) Peptides
GB9714276D0 (en) Peptides and related compounds
ZA984322B (en) Sucrose-binding proteins
GB9425380D0 (en) Peptides
EP0996457A4 (en) Fsh-releasing peptides
GB9720784D0 (en) Protein
GB9807890D0 (en) Peptides
GB9613705D0 (en) Novel peptides
GB9425381D0 (en) Peptides
GB9701024D0 (en) Peptides
GB9706556D0 (en) Peptides
GB9713146D0 (en) Peptides
GB9626362D0 (en) Peptides
GB9608430D0 (en) Peptides
GB9606765D0 (en) Peptides
GB9612648D0 (en) Peptides
GB9605904D0 (en) Peptides

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)